SCHEMBL6347129

SCHEMBL6347129

CS(=O)(=O)n1cccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19326996 0.72
SCHEMBL31747913 0.71 KMT2A (0.33)
SCHEMBL28939794 0.69
SCHEMBL28142047 0.69 CA1 (0.38)
SCHEMBL13698754 0.67 CA1 (0.37)
SCHEMBL29528071 0.67 CA1 (0.37)
SCHEMBL31713762 0.67 HTT (0.52)
SCHEMBL329182 0.67
SCHEMBL353422 0.67
SCHEMBL22494211 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12509453-B2 BRM/BRG1 inhibitors and uses thereof FOGHORN THERAPEUTICS INC. (US) 2025-12-30 US disclosed
US-11923508-B2 Electrolyte solution for lithium secondary battery and lithium secondary battery including the same SK ON CO., LTD. (KR) 2024-03-05 US disclosed
US-20240021877-A1 Electrolyte Solution for Lithium Secondary Battery and Lithium Secondary Battery Including the Same SK INNOVATION CO., LTD. (KR) 2024-01-18 US disclosed
EP-4307426-A1 ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING THE SAME SK On Co., Ltd. (KR) 2024-01-17 EP disclosed
CN-117393851-A Electrolyte for lithium secondary battery and lithium secondary battery comprising same SK新能源株式会社 2024-01-12 CN disclosed
CN-117377668-A Inhalant formulations of PGDH inhibitors and methods of use thereof 迈欧伏特治疗公司 2024-01-09 CN disclosed
US-20230348452-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2023-11-02 US disclosed
US-20230257373-A1 QUORUM SENSING INHIBITORS AND METHODS OF USE NATIONAL INSTITUTES OF HEALTH 2023-08-17 US disclosed
CN-115335043-A PGDH inhibitors and methods of making and using 迈欧伏特治疗公司 2022-11-11 CN disclosed
CN-115335373-A Compound and use thereof 福宏治疗公司 2022-11-11 CN disclosed
EP-1453604-A2 CATALYTIC COMPOSITION AND PROCESS FOR THE SELECTIVE OLIGOMERIZATION OF ETHYLENE TO LIGHT LINEAR ALPHA-OLEFINS Polimeri Europa S.r.l. (IT) 2004-09-08 EP disclosed
WO-2003053573-A2 CATALYTIC COMPOSITION AND PROCESS FOR THE SELECTIVE OLIGOMERIZATION OF ETHYLENE TO LIGHT LINEAR ALPHA-OLEFINS POLIMERI EUROPA S.P.A. (IT) 2003-07-03 WO disclosed
WO-2003050126-A1 COMPLEXES WITH SULFONIC LIGANDS FOR SELECTIVE OLIGOMERIZATION OF ETHYLENE POLIMERI EUROPA S.P.A. (IT) 2003-06-19 WO disclosed
US-5591854-A CATALYTIC CONDENSATION OF DIENES AND VINYLDIAZOMETHANEESTERS WAKE FOREST UNIVERSITY (US) 1997-01-07 US disclosed
WO-1996011928-A1 ENANTIOSELECTIVE SYNTHESIS OF SEVEN-MEMBERED CARBOCYCLES AND TROPANES WAKE FOREST UNIVERSITY (US) 1996-04-25 WO disclosed
US-4935440-A ANALGESICS, ANTIPYRETICS SYNTEX (U.S.A.) INC. (US) 1990-06-19 US disclosed
EP-0372982-A2 Pyrrole insecticides RHONE-POULENC AGROCHIMIE (FR) 1990-06-13 EP disclosed
US-4833155-A SKIN DISORDERS SYNTEX (U.S.A.) INC. (US) 1989-05-23 US disclosed
EP-0269981-A1 3-[alpha-(3,5-di-t-butyl-4-hydroxyphenyl)-alkanoyl]pyrroles, their de-oxy analogs, and therapeutic uses thereof SYNTEX (U.S.A.) INC. (US) 1988-06-08 EP disclosed
US-4235774-A ANIMAL GROWTH REGULATORS BAYER AKTIENGESELLSCHAFT (DE) 1980-11-25 US disclosed